Publication | Closed Access

Pharmacogenetic analyses of 2183 patients with advanced colorectal cancer; potential role for common dihydropyrimidine dehydrogenase variants in toxicity to chemotherapy

OncologyOncogenic AgentMedicinePharmacogenetic AnalysesColorectal CancerPathologyPotential RolePharmacogenomicsAdvanced Colorectal CancerPharmacologyCancer Research